Accelerated tau aggregation, apoptosis and neurological dysfunction caused by chronic oral administration of aluminum in a mouse model of tauopathies

Brain Pathology

Volumn 23, Issue 6, 2013, Pages 633-644

  Oshima, Etsuko ^a   Ishihara, Takeshi ^a,b   Yokota, Osamu ^a   Nakashima Yasuda, Hanae ^a   Nagao, Shigeto ^a   Ikeda, Chikako ^a   Naohara, Jun ^c   Terada, Seishi ^a   Uchitomi, Yosuke ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

Author keywords

aluminum; Alzheimer's disease; apoptosis; astrocyte; tau

Indexed keywords

ALUMINUM MALTOL; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; BRAIN DYSFUNCTION; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL TEST; HIPPOCAMPUS; INGESTION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PROTEIN AGGREGATION; SPINAL CORD; SUSPENSION; TAUOPATHY; TRANSGENIC MOUSE; WILD TYPE;

ALUMINUM; ALZHEIMER'S DISEASE; APOPTOSIS; ASTROCYTE; TAU;

ADMINISTRATION, ORAL; ALUMINUM; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MICE; MICE, TRANSGENIC; MOVEMENT; SPINAL CORD; TAU PROTEINS; TAUOPATHIES;

EID: 84885588060     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12059     Document Type: Article

References (52)

1. Akiyama H, Hosokawa M, Kametani F, Kondo H, Chiba M, Fukushima M, Tabira T, (2012) Long-term oral intake of aluminium or zinc does not accelerate Alzheimer pathology in AβPP and AβPP/tau transgenic mice. Neuropathology 32: 390-397.
2. Arai KI, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T, (1990) Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59: 783-836.
3. Aremu DA, Meshitsuka S, (2005) Accumulation of aluminum by primary cultured astrocytes from aluminum amino acid complex and its apoptotic effect. Brain Res 1031: 284-296.
4. Bizzi A, Crane RC, Autilio-Gambetti L, Gambetti P, (1984) Aluminum effect on slow axonal transport: a novel impairment of neurofilament transport. J Neurosci 4: 722-731.
5. Bowser R, Giambrone A, Davies P, (1995) FAC1, a novel gene identified with the monoclonal antibody Alz50, is developmentally regulated in human brain. Dev Neurosci 17: 20-37.
6. Braak H, Tredici KD, (2011) The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 121: 171-181.
7. Braak H, Thal DR, Ghebremedhin E, Tredici KD, (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70: 960-969.
8. Campbell A, Prasad KN, Bondy SC, (1999) Aluminum-induced oxidative events in cell lines: glioma are more responsive than neuroblastoma. Free Radic Biol Med 26: 1166-1171.
9. Campbell A, Yang EY, Tsai-Turton M, Bondy SC, (2002) Pro-inflammatory effects of aluminum in human glioblastoma cells. Brain Res 933: 60-65.
10. Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC, (2004) Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res 75: 565-572.
11. Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P, (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16: 285-304.
12. Erazi H, Sansar W, Ahboucha S, Gamrani H, (2010) Aluminum affects glial system and behavior of rats. C R Biol 333: 23-27.
13. Exley C, (2006) Aluminium and iron, but neither copper nor zinc, are key to the precipitation of beta-sheets of Abeta42 in senile plaque cores in Alzheimer's disease. J Alzheimers Dis 10: 173-177.
14. Fath T, Eidenmüller J, Brandt R, (2002) Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci 22: 9733-9741.
15. Fox LM, William CM, Adamowicz DH, Pitstick R, Carlson GA, Spires-Jones TL, Hyman BT, (2011) Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model. J Neuropathol Exp Neurol 70: 588-595.
16. Gillette-Guyonnet S, Andrieu S, Nourhashemi F, de La Gué ronnière V, Grandjean H, Vellas B, (2005) Cognitive impairment and composition of drinking water in women: findings of the EPIDOS Study. Am J Clin Nutr 81: 897-902.
17. Golub MS, Germann SL, (2001) Long-term consequences of developmental exposure to aluminum in a suboptimal diet for growth and behavior of Swiss Webster mice. Neurotoxicol Teratol 23: 365-372.
18. Gõmez M, Esparza JL, Cabré M, García T, Domingo JL, (2008) Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice, a model for Alzheimer's disease. Toxicology 249: 214-219.
19. Greenberg SG, Davies P, (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A 87: 5827-5831.
20. Griffioen KJ, Ghribi O, Fox N, Savory J, DeWitt DA, (2004) Aluminum maltolate-induced toxicity in NT2 cells occurs through apoptosis and includes cytochrome c release. Neurotoxicology 25: 859-867.
21. House E, Collingwood J, Khan A, Korchazkina O, Berthon G, Exley C, (2004) Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. J Alzheimers Dis 6: 291-301.
22. Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, Lee VM, (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24: 751-762.
23. Ishihara T, Zhang B, Higuchi M, Yoshiyama Y, Trojanowski JQ, Lee VM, (2001) Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol 158: 555-562.
24. Ishihara T, Higuchi M, Zhang B, Yoshiyama Y, Hong M, Trojanowski JQ, Lee VM, (2001) Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments. J Neurosci 21: 6026-6035.
25. Jicha GA, Bowser R, Kazam IG, Davies P, (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48: 128-132.
26. Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB, (2006) TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr Biol 16: 230-241.
27. Kihira T, Yoshida S, Uebayashi Y, Wakayana I, Yase Y, (1994) Experimental model of motor neuron disease: oral aluminum neurotoxicity. Biomed Res Tokyo 15: 27-36.
28. Kihira T, Yoshida S, Yase Y, Ono S, Kondo T, (2002) Chronic low-Ca/Mg high-Al diet induces neuronal loss. Neuropathology 22: 171-179.
29. Klatzo I, Wisniewski H, Streicher E, (1965) Experimental production of neurofibrillary degeneration. I. Light microscopic observations. J Neuropathol Exp Neurol 24: 187-199.
30. Kopeikina KJ, Carlson GA, Pitstick R, Ludvigson AE, Peters A, Luebke JI, et al (2011) Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain. Am J Pathol 179: 2071-2082.
31. Langui D, Anderton BH, Brion JP, Ulrich J, (1988) Effects of aluminium chloride on cultured cells from rat brain hemispheres. Brain Res 438: 67-76.
32. Langui D, Probst A, Anderton B, Brion JP, Ulrich J, (1990) Aluminium-induced tangles in cultured rat neurones. Enhanced effect of aluminium by addition of maltol. Acta Neuropathol 80: 649-655.
33. Loo DT, (2011) In situ detection of apoptosis by the TUNEL assay: an overview of techniques. Methods Mol Biol 682: 3-13.
34. McLachlan DR, Bergeron C, Smith JE, Boomer D, Rifat SL, (1996) Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology 46: 401-405.
35. Mizoroki T, Meshitsuka S, Maeda S, Murayama M, Sahara N, Takashima A, (2007) Aluminum induces tau aggregation in vitro but not in vivo. J Alzheimers Dis 11: 419-427.
36. Nakashima H, Ishihara T, Suguimoto P, Yokota O, Oshima E, Kugo A, et al (2005) Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies. Acta Neuropathol 110: 547-556.
37. Praticò D, Uryu K, Sung S, Tang S, Trojanowski JQ, Lee VM, (2002) Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J 16: 1138-1140.
38. Prolo P, Chiappelli F, Grasso E, Rosso MG, Neagos N, Dovio A, et al (2007) Aluminium blunts the proliferative response and increases apoptosis of cultured human cells: putative relationship to Alzheimer's disease. Bioinformation 2: 24-27.
39. Quintanilla RA, Orellana DI, González-Billault C, Maccioni RB, (2004) Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp Cell Res 295: 245-257.
40. Reusche E, Koch V, Lindner B, Harrison AP, Friedrich HJ, (2001) Alzheimer morphology is not increased in dialysis-associated encephalopathy and long-term hemodialysis. Acta Neuropathol 101: 211-216.
41. Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF, (2009) Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol 169: 489-496.
42. Savory J, Rao JK, Huang Y, Letada PR, Herman MM, (1999) Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging. Neurotoxicology 20: 805-817.
43. Savory J, Ghribi O, Forbes MS, Herman MM, (2001) Aluminium and neuronal cell injury: inter-relationships between neurofilamentous arrays and apoptosis. J Inorg Biochem 87: 15-19.
44. Savory J, Ghribi O, Forbes MS, Herman MM, (2001) The rabbit model system for studies of aluminum-induced neurofibrillary degeneration: relevance to human neurodegenerative disorders. In: Aluminum and Alzheimer's Disease. The Science That Describes the Link, C Exley, (ed.), pp. 203-219. Elsevier: Amsterdam.
45. Savory J, Herman MM, Ghribi O, (2003) Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain. J Inorg Biochem 97: 151-154.
46. Shaw CA, Petrik MS, (2009) Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. J Inorg Biochem 103: 1555-1562.
47. Tanemura K, Murayama M, Akagi T, Hashikawa T, Tominaga T, Ichikawa M, et al (2002) Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci 22: 133-141.
48. Walton JR, (2007) An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. J Inorg Biochem 101: 1275-1284.
49. Weaver CL, Espinoza M, Kress Y, Davies P, (2000) Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol Aging 21: 719-727.
50. Wills MR, Hewitt CD, Savory J, Herman MM, (1993) Long-term oral aluminum administration in rabbits. II. Brain and other organs. Ann Clin Lab Sci 1: 17-23.
51. 26Al incorporation into the brain of suckling rats through maternal milk. J Inorg Biochem 97: 155-160.
52. Zielke HR, Jackson MJ, Tildon JT, Max SR, (1993) A glutamatergic mechanism for aluminum toxicity in astrocytes. Mol Chem Neuropathol 19: 219-233.